Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tolerability and patient compliance.

S P Roose1

  • 1Department of Psychiatry, Late Life Depression Research Clinic, New York State Psychiatric Institute, Columbia University, New York 10032, USA.

The Journal of Clinical Psychiatry
|August 14, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A randomized, prospective pilot study of patient expectancy and antidepressant outcome.

Psychological medicine·2012
Same author

Current psychotherapy research methodology applied to psychoanalysis : a feasibility study.

The Journal of psychotherapy practice and research·2012
Same author

Depression and comorbid medical disorders: a reversal of causality.

CNS spectrums·2008
Same author

Quality of life, mood, and sexual function: a path analytic model of treatment effects in men with erectile dysfunction and depressive symptoms.

International journal of impotence research·2004
Same author

Depression in the long-term care patient: new tools for evaluation and treatment.

Journal of the American Medical Directors Association·2003
Same author

Depression, anxiety, and the cardiovascular system: the psychiatrist's perspective.

The Journal of clinical psychiatry·2002
Same journal

Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

The Journal of clinical psychiatry·2026
Same journal

Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters.

The Journal of clinical psychiatry·2026
Same journal

Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

The Journal of clinical psychiatry·2026
Same journal

Generative AI for the Clinical Psychopharmacologist: Is It Ready for Prime Time?

The Journal of clinical psychiatry·2026
Same journal

Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

The Journal of clinical psychiatry·2026
Same journal

The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

The Journal of clinical psychiatry·2026
See all related articles

Antidepressant receptor interactions influence treatment outcomes. Mirtazapine

Area of Science:

  • Pharmacology
  • Neuroscience
  • Psychiatry

Background:

  • Antidepressant medications interact with various receptors, influencing both therapeutic effects and adverse events.
  • Tolerability profiles are crucial for selecting antidepressants, impacting patient compliance and treatment success.
  • Newer antidepressants generally offer improved tolerability compared to older tricyclic compounds.

Purpose of the Study:

  • To analyze the distinct receptor interaction profiles of available antidepressants.
  • To correlate specific receptor interactions with differential tolerability and adverse event profiles.
  • To highlight the unique pharmacologic profile of mirtazapine in relation to its tolerability.

Main Methods:

  • Review of existing literature on antidepressant pharmacology and receptor binding profiles.

Related Experiment Videos

  • Analysis of clinical data regarding adverse events associated with different antidepressant classes.
  • Comparison of receptor interaction profiles of mirtazapine with selective serotonin reuptake inhibitors (SSRIs).

    • Main Results:

    • Mirtazapine and SSRIs exhibit favorable overall tolerability and safety profiles.
    • Mirtazapine's unique receptor interactions, including histamine (H1) and serotonin (5-HT2, 5-HT3) receptor blockade, are linked to specific tolerability aspects.
    • Histamine (H1) receptor interaction in mirtazapine may cause initial somnolence and weight gain; 5-HT2 blockade may reduce sexual dysfunction and agitation; 5-HT3 blockade may prevent gastrointestinal issues.

    Conclusions:

    • Understanding differential receptor interactions is key to predicting antidepressant tolerability.
    • Mirtazapine's distinct pharmacologic profile offers a unique tolerability advantage, particularly regarding gastrointestinal adverse events.
    • Clinicians can leverage knowledge of receptor profiles to optimize antidepressant selection for individual patients.